| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 02.02.
| What Baxter International Does With Its Cash | | 6 | Motley Fool |
| 30.01.
| Baxter (BAX) Gets FDA Approval for Expanded TISSEEL Indication | | 3 | StreetInsider.com |
| 30.01.
| Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery | | 41 | Business Wire |
| Baxter International Inc. (NYSE:BAX) announced today that the U.S. Food
and Drug Administration (FDA) has approved TISSEEL [Fibrin Sealant] to
include general hemostasis...
Mehr lesen zu:
Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery | |
| 28.01.
| Golf Clap for Baxter International | | 2 | Motley Fool |
| 27.01.
| Baxter erfüllt die Gewinnerwartungen | | 4 | boerse-express.com |
| 26.01.
| Pharmakonzern Baxter erfüllt die Gewinnerwartungen | | 76 | BörseGo |
| New York (BoerseGo.de) - Der Pharmakonzern Baxter hat im vierten Quartal sowohl beim Gewinn als auch beim Umsatz exakt die Analystenschätzungen getroffen. Der Umsatz im vierten Quartal betrug 3,59 Milliarden...
Mehr lesen zu:
Pharmakonzern Baxter erfüllt die Gewinnerwartungen | |
| 26.01.
| Baxter International's CEO Discusses Q4 2011 Results - Earnings Call Transcript | | 1 | Seeking Alpha |
| 26.01.
| Baxter Beats Estimates | | 1 | Zacks |
| 26.01.
| Baxter International Q4 Profit Drops | | 37 | AFX News |
| DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) Thursday reported
fourth quarter net income of $131.7 million compared to $133.6 million last
year. On a per share basis, profit was...
Mehr lesen zu:
Baxter International Q4 Profit Drops | |
| 26.01.
| Baxter profit rises 9%, sales up | | 4 | MarketWatch |
| 26.01.
| Baxter Reports Sales and EPS for Fourth Quarter and Full-Year 2011 in Line with Guidance | | 30 | Business Wire |
| Company Achieves Record Sales and Earnings in 2011
Baxter Provides Financial Outlook For 2012
Baxter International Inc. (NYSE:BAX) today...
Mehr lesen zu:
Baxter Reports Sales and EPS for Fourth Quarter and Full-Year 2011 in Line with Guidance | |
| 25.01.
| Baxter International Passes This Key Test | | 3 | Motley Fool |
| 24.01.
| From Earlier: Baxter to Initiate Second Phase III Trial Studying GAMMAGARD LIQUID for the Treatment of Alzheimer's Disease | | 1 | Benzinga.com |
| 24.01.
| Baxter To Begin Second Phase III Trial Studying Gammagard Liquid | | 63 | AFX News |
| DEERFIELD (dpa-AFX) - Baxter International Inc. (BAX) provided an update on
its clinical program evaluating the use of its Gammagard Liquid 10% [Immune
Globulin Infusion (Human)], for the...
Mehr lesen zu:
Baxter To Begin Second Phase III Trial Studying Gammagard Liquid | |
| 23.01.
| Baxter (BAX) Initiates Second GAMMAGARD LIQUID Phase II | | 1 | StreetInsider.com |
| 23.01.
| Baxter to Initiate Second Phase III Trial Studying GAMMAGARD LIQUID (IGIV) for the Treatment of Alzheimer's Disease | | 55 | Business Wire |
| Baxter International Inc. (NYSE:BAX) today provided an update on its
clinical program evaluating the use of its GAMMAGARD LIQUID 10% [Immune
Globulin Infusion (Human)]...
Mehr lesen zu:
Baxter to Initiate Second Phase III Trial Studying GAMMAGARD LIQUID (IGIV) for the Treatment of Alzheimer's Disease | |
| 23.01.
| Baxter Worth $65 Given Hospira's Shocking Troubles | | 6 | Seeking Alpha |
| 18.01.
| Baxter International Breaks Through Support at $51.70 | | 1 | SmarTrend |
| 16.01.
| Executives from Chrysler, Mitsubishi Power Systems Americas, and Baxter Healthcare Join Manufacturing Leadership Council | | 62 | PR Newswire |
| NEW YORK, Jan. 16, 2012 /PRNewswire/ --Manufacturing Enterprise Communications, the leading information resource for manufacturing executives, announces the appointment of eight additional...
Mehr lesen zu:
Executives from Chrysler, Mitsubishi Power Systems Americas, and Baxter Healthcare Join Manufacturing Leadership Council | |
| 13.01.
| Possible Bearish Inside Day Candle Pattern Detected for Baxter International | | 2 | SmarTrend |
